Go To Global Site
Welcome to UCB in the United States
UCB Alison Headshot Blog



UCB's Collaborative Approach to Improving Patient Care and Outcomes in Osteoporosis

At UCB, we are using our passion and expertise to address gaps in post-fracture care to provide patients the support they need. This Osteoporosis Awareness Month, read from Alison Kocanda, Head of U.S. Bone, as she shares how UCB is supporting patients through education and resources.



Bridging the Gaps in Osteoporosis

Every three seconds - that is how often it is estimated that a fragility fracture occurs. Although nearly 9 million fractures occur annually worldwide, oftentimes people think fragile bones are an inevitable part of getting older, but a fracture may more commonly be the result of an underlying condition: osteoporosis. This May for Osteoporosis Awareness Month, we’re highlighting things to know about osteoporosis and our commitment to addressing the gaps impacting those living with the disease.



UCB Statement on COVID-19 Outbreak

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.



Recognizing the Many Forms of Arthritis this Arthritis Awareness Month

UCB is passionate about transforming the lives of people living with severe diseases and uncovering the intersections of scientific understanding and patient needs. This May, we are honoring Arthritis Awareness Month and Spondyloarthritis Awareness Month by exploring the impacts of different kinds of arthritis on patients. Learn more about psoriatic arthritis, rheumatoid arthritis, and non-radiographic axial spondyloarthritis, their prevalence, and how individuals living with these diseases are impacted.



Disease Spotlight: Psoriatic Arthritis

Developing impactful and innovative solutions for patients whose lives have been challenged by severe diseases is our focus at UCB. This Arthritis Awareness Month, learn more about psoriatic arthritis (PsA), one of the many types of arthritic disease.



UCB Volunteers Help Communities Impacted by COVID-19

Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.



Minimizing Our Environmental Footprint

During the COVID-19 pandemic, we’re reminded of the many challenges facing our world. At UCB, we recognize the challenges facing the world, from climate change to rising inequalities, are inextricably linked and that businesses have a key role to play to ensure a sustainable future for all. This Earth Day, we’re highlighting some of our progress as it relates to minimizing our environmental footprint across the value chain.



Celebrating Warriors with Parkinson’s Disease

Today, across the globe, people are being impacted by COVID-19, causing not only illness, but also uncertainty and fear. With April being Parkinson’s Awareness month, we're sharing the inspirational stories of PD Warriors who are breaking barriers despite their diagnosis to spread a little positivity during this challenging time. These warriors recently shared their stories with More Than Motion, UCB’s community dedicated to raising awareness of the realities of living with Parkinson's disease (PD), and we're honored to feature them this month.



UCB’s Three-Point Plan to Help Combat COVID-19 in the U.S.

With the U.S. heavily impacted by the novel coronavirus, COVID-19, UCB is committed to playing our part to contribute our scientific expertise and resources to the greater response effort happening across the country and the world. This includes expanding our assistance programs to further help patients impacted by the pandemic.



UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients

UCB completes the acquisition of Ra Pharmaceuticals – to deliver differentiated therapies to patients.